CYP19A1 and coronary artery disorder: We sought to examine both the overall effect of CYP19A1 and to explicitly test for gene*sex interactions and sex-specific differences in these genetic variants and outcome using two independent coronary artery disease (CAD) populations, one with acute coronary syndromes (ACS) and one with stable CAD.